ISDA

Entry Detail

PDB ID:

5U6J

Keywords:

Title:

Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]amino}benzamide

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Cricetinae

PDB Version:

Deposition Date:

2016-12-08

Release Date:

2017-05-10

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Coagulation factor VII Heavy Chain
Chain IDs:A (auth: H)
Chain Length:254
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Protein Blast

Polymer Type:polypeptide(L)
Description:Coagulation factor VII Light Chain
Chain IDs:B (auth: L)
Chain Length:55
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Ligand Molecules

82J

GOL

SO4

Primary Citation

Neutral macrocyclic factor VIIa inhibitors.

Wurtz, N.R, Parkhurst, B.L, DeLucca, I, Glunz, P.W, Jiang, W, Zhang, X, Cheney, D.L, Bozarth, J.M, Rendina, A.R, Wei, A, Harper, T, Luettgen, J.M, Wu, Y, Wong, P.C, Seiffert, D.A, Wexler, R.R, Priestley, E.S.Show

Bioorg. Med. Chem. Lett. 27 2650 2654 (2017)

PMID: 28460818 DOI: 10.1016/j.bmcl.2017.04.008

Abstact

Factor VIIa (FVIIa) inhibitors have shown strong antithrombotic efficacy in preclinical thrombosis models with limited bleeding liabilities. Discovery of potent, orally active FVIIa inhibitors has been largely unsuccessful due to the requirement of a basic P1 group to interact with Asp189 in the S1 binding pocket, limiting their membrane permeability. We have combined recently reported neutral P1 binding substituents with a highly optimized macrocyclic chemotype to produce FVIIa inhibitors with low nanomolar potency and enhanced permeability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures